Final Report of a Phase III Randomized Trial of Amifostine as a Radioprotectant in Head and Neck Cancer

Todd Doyle, MD
OncoLink Assistant Editor
Ultima Vez Modificado: 1 de noviembre del 1999

Translation for this article does not exist

Blogs

The Power of a Cancer Support Group
by Bob Riter
May 26, 2016